Pages that link to "Q74327677"
Jump to navigation
Jump to search
The following pages link to Cerebral MR perfusion imaging: first clinical application of a 1 M gadolinium chelate (Gadovist 1.0) in a double-blinded randomized dose-finding study (Q74327677):
Displaying 13 items.
- Dynamic susceptibility contrast MRI of gliomas (Q30784418) (← links)
- Absolute quantification of perfusion using dynamic susceptibility contrast MRI: pitfalls and possibilities. (Q33517222) (← links)
- MR Imaging of Neoplastic Central Nervous System Lesions: Review and Recommendations for Current Practice (Q34053148) (← links)
- Multicentre imaging measurements for oncology and in the brain. (Q34203974) (← links)
- Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study (Q35390321) (← links)
- Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging (Q37317806) (← links)
- Effect of imaging time in the magnetic resonance detection of intracerebral metastases using single dose gadobutrol (Q37541200) (← links)
- Gadobutrol: a review of its use for contrast-enhanced magnetic resonance imaging in adults and children (Q38084164) (← links)
- Using a 1 M Gd‐chelate (gadobutrol) for total‐body three‐dimensional MR angiography: Preliminary experience (Q39648179) (← links)
- Role of diffusion- and perfusion-weighted MR imaging for brain tumour characterisation (Q48621243) (← links)
- Brain MR perfusion imaging in humans (Q48694773) (← links)
- How do concentration and dosage of the contrast agent affect the signal change in perfusion-weighted magnetic resonance imaging? A computer simulation (Q48795574) (← links)
- Current awareness (Q77629008) (← links)